L&C BIO Co.,LTD (KOSDAQ:290650)
85,300
-3,800 (-4.26%)
At close: Feb 6, 2026
278.27% (1Y)
| Market Cap | 2.12T +249.9% |
| Revenue (ttm) | 79.99B +19.4% |
| Net Income | 78.00B |
| EPS | 3,050.54 |
| Shares Out | 24.84M |
| PE Ratio | 27.71 |
| Forward PE | n/a |
| Dividend | 50.00 (0.06%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 459,527 |
| Average Volume | 664,250 |
| Open | 86,500 |
| Previous Close | 89,100 |
| Day's Range | 84,500 - 88,800 |
| 52-Week Range | 18,490 - 97,500 |
| Beta | 1.47 |
| RSI | 64.62 |
| Earnings Date | Feb 13, 2026 |